Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase I dose escalation study of NMS-1286937, an orally available Polo-Like Kinase 1 inhibitor, in patients with advanced or metastatic solid tumors.AuthorsWeiss, Glen J.; Jameson, Gayle; Von Hoff, Daniel D.; Valsasina, Barbara; Davite, Cristina; Di Giulio, Claudia; Fiorentini, Francesco; Alzani, Rachele; Carpinelli, Patrizia; Di Sanzo, Alessandro; Galvani, Arturo; Isacchi, Antonella; Ramanathan, Ramesh K.PublicationInvestigational New Drugs, 2018, Vol 36, Issue 1, p85ISSN0167-6997Publication typeArticleDOI10.1007/s10637-017-0491-7